Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study - Fatih Kus; Fatih Atalah; Gokhan Sahin; Caner Kapar; Damla Gunenc; Erkut Demirciler; Alper Topal; Halil Goksel Guzel; Yakup Duzkopru; Mert Erciyestepe; Ilgin Koc Kus; Omer Denizhan Tatar; et al. (BMC Cancer, 2026)